Predictors of the development of abnormal patterns of circadian blood pressure rhythm in patients with hypertension after a new coronavirus infection

Abstract

Objective. To determine the predictors of the development of abnormal patterns of circadian blood pressure (BP) rhythm in patients with arterial hypertension (AH) after a new coronavirus infection (NСVI).

Materials and methods. The study is a comparative clinical research of the same patients with hypertension before and after NCVI with retrospective evaluation of the data. Within 2 years from 842 patients with cardiovascular risk factors, according to the inclusion and non-inclusion criteria 70 patients with target levels of office BP, home monitoring and 24-hour blood pressure monitoring (ABPM) on the background of a continuous antihypertensive therapy were included in the study. Abnormal patterns of circadian BP were recorded after NCVI during ABPM in all of them. All patients with hypertension underwent a complete examination before and after NCVI.

Results. After NCVI in patients with AH who had achieved the target ranges of office BP before its development, at home measurement and ABPM against the background of continuous antihypertensive therapy with high adherence to treatment, in more than 50 % of patients BP readings were not in the target values, in more than 50 % of the examined patients, BP variability was higher than the permissible values, in 73 % of patients the average daily BP was above 53 mm Hg. Abnormal patterns of circadian BP rhythm in patients with hypertension after NCVI were detected in 61.5 %: "Non-dipper" in 28.6 %; "Night-dipper" – in 21.9 %, masked nocturnal hypertension – in 17.1 %.

Conclusion. The indicative significance of the development of abnormal patterns of circadian BP rhythm in patients with hypertension after NCVI was demonstrated by 3 qualitative indicators: glomerular filtration rate with cystatin C < 60 ml/min/1.73 m2, cardio-ankle vascular index (CAVI) ≥ 9, and a high frequency of AGT gene polymorphism – T/T genotype (in 54.3 % of patients).

Keywords

Circadian blood pressure rhythm / post-COVID syndrome

References

[1] Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023; 21: 133–146. DOI: 10.1038/s41579-022-00846-2.

[2] Bielecka E., Sielatycki P., Pietraszko P., Zapora-Kurel A., Zbroch E. Elevated Arterial Blood Pressure as a Delayed Complication Following COVID-19-A Narrative Review. Int J Mol Sci. 2024; 25 (3): 1837. DOI:10.3390/ijms25031837.

[3] Schmidt-Lauber C., Alba Schmidt E., Hänzelmann S., Petersen E.L., Behrendt C.A., Twerenbold R. et al. Increased blood pressure after nonsevere COVID-19. J Hypertens. 2023; 41 (11): 1721–1729. DOI: 10.1097/HJH.0000000000003522.

[4] Кобалава Ж.Д., Конради А.О., Недогода С.В., Шляхто Е.В., Арутюнов Г.П., Баранова Е.И. и др. Артериальная гипертензия у взрослых. Клинические рекомендации 2020. Российский кардиологический журнал 2020; 25 (3): 3786. DOI: 10.15829/1560-4071-2020-3-3786 / Kobalava Zh.D., Konradi A.O., Nedogoda S.V., Shlyakhto E.V., Arutyunov G.P., Baranova E.I. et al. Arterial hypertension in adults. Clinical guidelines 2020. Russian Journal of Cardiology 2020; 25 (3): 3786. DOI: 10.15829/1560-4071-2020-3-3786 (in Russian).

[5] Gorbunov V.M. Position of 24-hour ambulatory blood pressure monitoring in modern practice. Cardiovascular Therapy and Prevention 2022; 21 (12): 3456. DOI: 10.15829/1728-8800-2022-3456.

[6] Mancia G., Kreutz R., Brunström M., Burnier M., Grassi G., Januszewicz A. et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023; 41 (12): 1874–2071. DOI: 10.1097/HJH.0000000000003480.

[7] Морозова М.А., Потанин С.С., Бениашвили А.Г., Бурминский Д.С., Лепилкина Т.А., Рупчев Г.Е., Кибитов А.А. Валидация русскоязычной версии Госпитальной шкалы тревоги и депрессии в общей популяции. Профилактическая медицина 2023; 26 (4): 7–14. DOI: 10.17116/profmed2023260417 / Morozova M.A., Potanin S.S., Beniashvili A.G., Burminsky D.S., Lepilkina T.A., Rupchev G.E., Kibitov A.A. Validation of the Russian-language version of the Hospital Anxiety and Depression Scale in the general population. Preventive medicine 2023; 26 (4): 7–14. DOI: 10.17116/profmed20232604177 (in Russian).

[8] Ogungbe O., Gilotra N.A., Davidson P.M., Farley J.E., Himmelfarb C.R.D., Post W.S., Commodore-Mensah Y. Cardiac postacute sequelae symptoms of SARS-CoV-2 in community-dwelling adults: Cross-sectional study. Open Heart. 2022; 9: e002084. DOI: 10.1136/openhrt-2022-002084.

[9] Cohen K., Ren S., Heath K., Dasmariñas M.C., Jubilo K.G., Guo Y., Lipsitch M., Daugherty S.E. Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 infection: Retrospective cohort study. BMJ. 2022; 376: e068414. DOI: 10.1136/bmj-2021-068414.

[10] Jennifer K., Shirley S.B.D., Avi P., Daniella R.-C., Naama S.S., Anat E.Z., Miri M.-R. Post-acute sequelae of COVID-19 infection. Prev. Med. Rep. 2023; 31: 102097. DOI: 10.1016/j.pmedr.2022.102097.

[11] Cénat J.M., Blais-Rochette C., Kokou-Kpolou C.K., Noorishad P.-G., Mukunzi J.N., McIntee S.-E., Dalexis R.D., Goulet M.-A., Labelle P.R. Prevalence of symptoms of depression, anxiety, insomnia, posttraumatic stress disorder, and psychological distress among populations affected by the COVID-19 pandemic: A systematic review and meta-analysis. Psychiatry Res. 2021; 295: 113599. DOI: 10.1016/j.psychres.2020.113599.

[12] Akpek M. Does COVID-19 Cause Hypertension? Angiology. 2022; 73: 682–687. DOI: 10.1177/00033197211053903.

[13] Podzolkov V., Bragina A., Tarzimanova A., Vasilyeva L., Shvedov I., Druzhinina N. et al. Association of COVID-19 and Arterial Stiffness Assessed using Cardiovascular Index (CAVI). Curr Hypertens Rev. 2024; 20 (1): 44–51. DOI:10.2174/0115734021279173240110095037.

[14] Gómez-Sánchez L, Tamayo-Morales O., Suárez-Moreno N., Bermejo-Martín J.F., Domínguez-Martín A., Martín-Oterino J.A. et al. ICOPER investigators group. Relationship between the structure, function and endothelial damage, and vascular ageing and the biopsychological situation in adults diagnosed with persistent COVID (BioICOPER study). A research protocol of a cross-sectional study. Front Physiol. 2023; 14: 1236430. DOI: 10.3389/fphys.2023.1236430.

RIGHTS & PERMISSIONS

Eco-Vector